Everolimus in Pancreatic Neuroendocrine Tumors and Carcinoid Tumors
0 Views
administrator
07/09/23
Jonathan R. Strosberg, MD; James C. Yao, MD; and Matthew H. Kulke, MD, discuss the role of everolimus, an mTOR inhibitor, in the management of neuroendocrine tumors (NETs).
Show more
Facebook Comments
No comments found